Radiopharm Theranostics Limited

Radiopharm Theranostics Limited

RAD.AX
Radiopharm Theranostics LimitedAU flagAustralian Securities Exchange
0.02
AUD
- -
- -
47.30MMarket Cap

Radiopharm Theranostics Limited (RAD.AX) Stock Split History

Learn about Radiopharm Theranostics Limited's most recent 529-for-500 basis stock split on November 02, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Radiopharm Theranostics Limited's most recent stock split

Split Date: 2023-11-02
Split Ratio: 529:500
Price Before Split: $0.08
Price After Split: $0.08

Developer API

Get RAD.AX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/RAD.AX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.06 times more shares (a 529:500 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Radiopharm Theranostics Limited's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-11-02529:500No$0.08$0.08
2022-10-20517:500No$0.13$0.12

About Radiopharm Theranostics Limited

Company overview and industry information

Radiopharm Theranostics Limited (RAD.AX) operates in the Biotechnology industry. The recent 529-for-500 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Biotechnology
Go to Radiopharm Theranostics Limited Summary

Last updated: 7/7/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.